Menu

Find clinical trials for Glioblastoma (GBM) in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma
A woman searches for clinical trials

Glioblastoma (GBM) trials near New York, NY, USA:

FRONTIER Study is a prospective, interventional, single-arm, multi-center, study to assess the safety and technical feasibility of TheraSphere GBM...

Active, not recruiting
Recurrent Glioblastoma
Glioblastoma Multiforme
Device: TheraSphere GBM

Early Phase 1

Boston Scientific
Boston Scientific

New York, New York, United States and 4 other locations

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-9012

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

New York, New York, United States and 20 other locations

A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)...

Active, not recruiting
Glioblastoma Multiforme
Drug: ACP-196

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

New York, New York, United States and 6 other locations

(MTA-based vaccine) in combination with standard care treatment of glioblastoma (GBM) and Tumor Treating Fields (TTFields).The stud...

Active, not recruiting
Glioblastoma
Biological: Peptides
Drug: Poly-ICLC

Phase 1

Albert Einstein College of Medicine
Albert Einstein College of Medicine

Bronx, New York, United States of America

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

New York, New York, United States and 61 other locations

therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...

Enrolling
Glioblastoma Multiforme of Brain
Radiation: Radiotherapy
Procedure: Standard of Care

Phase 2, Phase 3

TVAX Biomedical

Pennington, New Jersey, United States and 7 other locations

with ipilimumab and surgery when used in the treatment of recurrent glioblastoma.The names of the study drugs involved in this study are:* N...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Ipilimumab-Placebo
Drug: Nivolumab-Placebo

Phase 1

Patrick Wen, MD

New York, New York, United States and 3 other locations

The purpose of this study is to find out if performing additional Magnetic Resonance Image (MRI) scans of the subjects' brain during each week of the...

Enrolling
Glioblastoma
Astrocytoma
Other: Adaptive Radiotherapy
Columbia University
Columbia University

New York, New York, United States

as a monotherapy in participants with newly diagnosed or recurrent epidermal growth factor receptor variant III (EGFRvIII)-positive glioblastoma...

Active, not recruiting
Glioblastoma
Drug: RO7428731

Phase 1

Roche
Roche

New York, New York, United States and 8 other locations

and tolerability of these combinations in adult participants with glioblastoma (GBM). Arm B which was previously added to the proto...

Enrolling
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Astrocytoma, Grade III
Drug: Debio 0123
Drug: Temozolomide

Phase 1, Phase 2

Debiopharm
Debiopharm

New York, New York, United States and 11 other locations